US 12,343,537 B2
Neurostimulation for treating sensory deficits, and associated systems and methods
Dongchul Lee, Agua Dulce, CA (US); Kerry Bradley, Glendale, CA (US); and Kwan Yeop Lee, Poway, CA (US)
Assigned to Nevro Corporation, Redwood City, CA (US)
Filed by Nevro Corp., Redwood City, CA (US)
Filed on Apr. 16, 2024, as Appl. No. 18/637,299.
Application 18/637,299 is a continuation of application No. 18/344,579, filed on Jun. 29, 2023, granted, now 11,986,657.
Claims priority of provisional application 63/357,798, filed on Jul. 1, 2022.
Prior Publication US 2025/0041601 A1, Feb. 6, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01)
CPC A61N 1/36062 (2017.08) [A61N 1/36171 (2013.01); A61N 1/36157 (2013.01); A61N 1/36175 (2013.01)] 26 Claims
OG exemplary drawing
 
1. A method of treating a patient having sensation loss associated with diabetic neuropathy, the patient having a first subset of neurons and a second subset of neurons, with at least the second subset of neurons demonstrating a pathological afferent neural response to a sensory input, the method comprising:
at least partially in response to identifying that the second subset of neurons demonstrate the pathological afferent neural response to a sensory input, programming a signal generator to deliver, via at least one implanted signal delivery element, a paresthesia-free electrical signal having a frequency within a frequency range of from about 200 Hz to about 100 kHz to the patient's spinal cord,
wherein the paresthesia-free electrical signal activates one or more neurons of the first subset of neurons within the spinal cord to modify a state of one or more neurons of the second subset of neurons and thereby increase afferent neural activity generated in the one or more neurons of the second subset of neurons in response to a sensory input.